Michael Barbella, Managing Editor12.05.22
Vicarious Surgical Inc.'s Board of Directors is undergoing some changes.
Technology-focused venture capitalists Dror Berman and Samir Kaul have resigned from the governing body, and Beverly Huss has beem appointed to the board, serving on the Audit Committee.
Huss co-founded and was CEO of Pagonia Medical, a development stage company in the tissue preservation market, where she led the incorporation efforts and seed capital financing. Prior to this, Huss was CEO of Qool Therapeutics Inc., a therapeutic hypothermia and medical device company, and CEO of Vibrynt Inc., a start-up medical device company dedicated to creating minimally invasive therapies for patients suffering from morbid obesity. From 1986 to 2005, Huss served in various general management roles of increasing responsibility within the research and development, regulatory affairs, marketing and sales departments of Guidant Corporation, a medical device company focused on treatment of cardiac rhythm management, cardiovascular and peripheral vascular disease through minimally invasive therapies, until its acquisition by Boston Scientific Corporation.
“I am honored to join the Vicarious Surgical Board at this exciting phase for the company,” Huss said. “The Vicarious system possesses a number of differentiating factors that I believe hold the potential to transform the standard in surgical robotics. I look forward to working closely with my fellow board members and the Vicarious leadership team in their pursuit to bring these advancements to patients in need.”
Huss is a veteran board member with nearly two decades of board experience and presently resides on the boards of Accuray Incorporated, Ancora Heart Inc., Iridex Corporation, and Madorra Inc. She earned a bachelor of science degree in metallurgical engineering from the University of Illinois Urbana-Champaign and a master’s degree in technology management from Pepperdine University.
“On behalf of the Board, I would like to thank Samir and Dror for their meaningful contributions and dedication to Vicarious Surgical over the past years; both have been instrumental in Vicarious’ evolution from tech startup into the public, surgical robotic company that it is today,” Board Chairman David Styka said. “We are excited to welcome Beverly to the Vicarious team, where she will undoubtedly be a tremendous resource given her decades of broad experience in the medical device field and reputation as a visionary leader earned through successful pursuits across research and development, manufacturing, marketing and commercialization. Beverly’s involvement will be invaluable in advancing the Vicarious strategy.”
Founded in 2014, Vicarious Surgical is a next-generation robotics company developing a technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The company’s surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd., and Philip Liang’s E15 VC. The company is headquartered in Waltham, Mass.
Technology-focused venture capitalists Dror Berman and Samir Kaul have resigned from the governing body, and Beverly Huss has beem appointed to the board, serving on the Audit Committee.
Huss co-founded and was CEO of Pagonia Medical, a development stage company in the tissue preservation market, where she led the incorporation efforts and seed capital financing. Prior to this, Huss was CEO of Qool Therapeutics Inc., a therapeutic hypothermia and medical device company, and CEO of Vibrynt Inc., a start-up medical device company dedicated to creating minimally invasive therapies for patients suffering from morbid obesity. From 1986 to 2005, Huss served in various general management roles of increasing responsibility within the research and development, regulatory affairs, marketing and sales departments of Guidant Corporation, a medical device company focused on treatment of cardiac rhythm management, cardiovascular and peripheral vascular disease through minimally invasive therapies, until its acquisition by Boston Scientific Corporation.
“I am honored to join the Vicarious Surgical Board at this exciting phase for the company,” Huss said. “The Vicarious system possesses a number of differentiating factors that I believe hold the potential to transform the standard in surgical robotics. I look forward to working closely with my fellow board members and the Vicarious leadership team in their pursuit to bring these advancements to patients in need.”
Huss is a veteran board member with nearly two decades of board experience and presently resides on the boards of Accuray Incorporated, Ancora Heart Inc., Iridex Corporation, and Madorra Inc. She earned a bachelor of science degree in metallurgical engineering from the University of Illinois Urbana-Champaign and a master’s degree in technology management from Pepperdine University.
“On behalf of the Board, I would like to thank Samir and Dror for their meaningful contributions and dedication to Vicarious Surgical over the past years; both have been instrumental in Vicarious’ evolution from tech startup into the public, surgical robotic company that it is today,” Board Chairman David Styka said. “We are excited to welcome Beverly to the Vicarious team, where she will undoubtedly be a tremendous resource given her decades of broad experience in the medical device field and reputation as a visionary leader earned through successful pursuits across research and development, manufacturing, marketing and commercialization. Beverly’s involvement will be invaluable in advancing the Vicarious strategy.”
Founded in 2014, Vicarious Surgical is a next-generation robotics company developing a technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The company’s surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd., and Philip Liang’s E15 VC. The company is headquartered in Waltham, Mass.
